“…Aging also produces an increased incidence of abnormal DSTs (Stangl et al, 1986;Sharma et al, 1988) an association that is even more pronounced in elderly depression (Ritchie et al, 1990b;Brodaty et al, 1991). The close interrelationship between glucocorticoid status and serotonergic function (Chan and Lee, 1985;Arora and Meltzer, 1986;Kitayama et al, 1988;Shimoda et al, 1988;Joëls and De Kloet, 1991;Pepin et al, 1992) suggests that HPA dysregulation may have a significant impact on the reactivity to tricyclic antidepressants and particularly the serotonin-specific reuptake inhibitors that have become the mainstay of depression therapy (Carroll et al, 1981;Aghajanian et al, 1993;Young, 1994). Central serotonergic pathways are, in turn, major contributors to HPA control (Stokes et al, 1987;Korte et al, 1991) and, again, this regulation is disrupted in depression (Koenig et al, 1987;Lesch et al, 1990;Maes et al, 1991).…”